NEJM Study Seeks Best Treatment For Elderly Mantle Cell Patients

Mantle cell lymphoma remains one of the more elusive subtypes of B-cell non-Hodgkin's lymphomas, and patient outcomes remain fairly poor. This is especially true of the elderly. Fortunately, a recent paper published in the New England Journal of Medicine might help make treatment options a little clearer for oncologists treating these patients.

The trial

Researchers from the Netherlands carried out a randomized trial of more than 500 patients diagnosed with mantle cell lymphoma (only stage I diagnoses were excluded), with a median age of 70. Patients were randomized into one of two treatment arms:

-- Six cycles of rituximab, fludarabine, and cyclophosphamide (R-FC) every 28 days
-- Eight cycles of rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) every 21 days

Patients who showed a response to treatment were then randomized again into either maintenance therapy with rituximab, or maintenance therapy with interferon alfa.

The results

Overall survival was higher in the R-CHOP arm (4 year survival rate 62%) compared to the R-FC arm (47%), and the former arm also saw fewer hematologic toxic effects.

Furthermore, patients randomized to rituximab maintenance saw a significantly higher 4 year survival (87%) compared to interferon alfa (63%).

Implications

Their results suggest that R-CHOP followed by rituximab maintenance therapy offers the elderly mantle cell lymphoma patient with the greatest odds of treatment success.

Source: NEJM

More Articles

More Articles

Mantle cell lymphoma (MCL) is a rare type of B-Cell lymphoma. It presents itself in the mantle zone of lymph nodes...

Large Cell Lymphoma (LCL) is typically an aggressive (fast growing) cancer of either the B cell or T cell type. They are one of the most common...

Indolent Lymphoma, or Indolent Non-Hodgkin’s Lymphomas (NHLs), are slow growing, low-grade cancers (as opposed to ...

A lymphoma prognosis varies greatly depending on the type of lymphoma. There are more than 35 types of lymphoma, including 5 types of...

Lymphomas are classified based on the type of cells involved. Non-Hodgkin’s lymphomas are marked by mutations of...

Hodgkin's Lymphoma (Disease) has a colorful history: It was not the first cancer discovered but it was one of the first in which treatments were...

There are two types of cancer: benign and malignant. Benign cancers are the kind that don't spread and don't threaten one's life. Malignant...

Cancer bracelets are undeniably popular, and if purchased through reliable sources such as major charities, they help contribute to the fight...

Hodgkin's Disease—also referred to as Hodgkin's Lymphoma, these are the exact same diseases, just...

Lymphoma is a cancer of the b- and t-cell lymphocytes, part of the immune system. They account for the most frequent head and neck malignancies....

Lymphoma is a cancer of the lymphatic system, causing B-cell or...

Lymphoma is a cancer affecting the white blood cells (lymphocytes) of the body's immune system. The cells begin to grow abnormally and much faster...

As a kind of cancer, lymphoma attacks the lymphocytes and lymph nodes that are part of the immune system. Head and neck lymphoma results when...

Some cancers have clear environmental causes. Oral cancer is strongly tied to the use of chewing tobacco, and lung cancer is well-known to be much...

The Follicular Lymphoma International Prognostic Index, or FLIPI, is a standardized guide to help oncological diagnosticians accurately calculate...